Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older?

Digestion

Volumn 81, Issue 4, 2010, Pages 237-243

  Lee, Jin Ha ^a   Cheon, Jae Hee ^a   Moon, Chang Mo ^a   Park, Jae Jun ^a   Hong, Sung Pil ^a   Kim, Tae Il ^a   Kim, Won Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Age; Prognosis; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CLINICAL FEATURE; DIARRHEA; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGE FACTORS; BIOPSY, NEEDLE; COHORT STUDIES; COLITIS, ULCERATIVE; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTESTINAL MUCOSA; KOREA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 75149136631     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253850     Document Type: Article

References (30)

1. Ananthakrishnan AN, McGinley EL, Binion DG: Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009; 15: 182-189.
2. Robertson DJ, Grimm IS: Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2001; 30: 409-426. (Pubitemid 32552543)
3. Chow DK, Leong RW, Tsoi KK, Ng SS, Leung WK, Wu JC, Wong VW, Chan FK, Sung JJ: Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol 2009; 104: 647-654.
4. Almogy G, Bodian CA, Greenstein AJ: Surgery for late-onset ulcerative colitis: predictors of short-term outcome. Scand J Gastroenterol 2002; 37: 1025-1028.
5. Riegler G, Tartaglione MT, Carratu R, D'Inca R, Valpiani D, Russo MI, Papi C, Fiorentini MT, Ingrosso M, Andreoli A, Vecchi M: Agerelated clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian colon-rectum study group). Dig Dis Sci 2000; 45: 462-465. (Pubitemid 30171918)
6. Jones HW, Hoare AM: Does ulcerative colitis behave differently in the elderly? Age Ageing 1988; 17: 410-414.
7. Zimmerman J, Gavish D, Rachmilewitz D: Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985; 7: 492-498. (Pubitemid 16175467)
8. Park SH, Kim YM, Yang SK, Kim SH, Byeon JS, Myung SJ, Cho YK, Yu CS, Choi KS, Chung JW, Kim B, Choi KD, Kim JH: Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007; 13: 278-283. (Pubitemid 46465908)
9. Ouyang Q, Tandon R, Goh KL, Ooi CJ, Ogata H, Fiocchi C: The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005; 21: 408-413. (Pubitemid 40961165)
10. O'Morain C, Tobin A, Leen E, Suzuki Y, O'Riordan T: Criteria of case definition in Crohn's disease and ulcerative colitis. Scand J Gastroenterol Suppl 1989; 170: 7-11; discussion 16-19. (Pubitemid 20015812)
11. Cheon JH, Kim WH: Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver 2007; 1: 118-125.
12. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lemann M, Marteau P, Rutgeerts P, Scholmerich J, Sutherland LR: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132: 763-786. (Pubitemid 46306135)
13. Powell-Tuck J, Bown RL, Lennard-Jones JE: A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13: 833-837.
14. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA: Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008; 103: 1203-1209. (Pubitemid 351677969)
15. Satsangi J, Silverberg MS, Vermeire S, Colombel JF: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753. (Pubitemid 43764536)
16. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429. (Pubitemid 34851835)
17. Carter MJ, Lobo AJ, Travis SP, IBD Section, British Society of Gastroenterology: Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53(suppl 5):V1-V16.
18. Fujimoto T, Kato J, Nasu J, Kuriyama M, Okada H, Yamamoto H, Mizuno M, Shiratori Y: Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol 2007; 19: 229-235. (Pubitemid 46263280)
19. Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Sandborn WJ: Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940- 2000. Inflamm Bowel Dis 2007; 13: 254-261.
20. Lok KH, Hung HG, Ng CH, Kwong KC, Yip WM, Lau SF, Li KK, Li KF, Szeto ML: Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol 2008; 23: 406-410.
21. Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Martorelli V, Quaglino D: The immune system in the elderly: II. Specific cellular immunity. Immunol Res 1999; 20: 109-115.
22. Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, Cohen AS: The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985; 28: 987-994.
23. Childs B, Scriver CR: Age at onset and causes of disease. Perspect Biol Med 1986; 29: 437-460.
24. Polito JM 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM: Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580-586. (Pubitemid 26293220)
25. Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters FL, Russel MG, Stockbrugger RW: Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009; 104: 371-383.
26. Andres PG, Friedman LS: Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255-281, vii. (Pubitemid 29306479)
27. Baumgart DC, Sandborn WJ: Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657. (Pubitemid 46722637)
28. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, Glessner JT, Santa E, Willson T, Eckert AW, Bonkowski E, Shaner JL, Smith RM, Otieno FG, Peterson N, Abrams DJ, Chiavacci RM, Grundmeier R, Mamula P, Tomer G, Piccoli DA, Monos DS, Annese V, Denson LA, Grant SF, Hakonarson H: Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 2008; 40: 1211-1215.
29. Horne R, Parham R, Driscoll R, Robinson A: Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 837-844.
30. D'Inca R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC: Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008; 27: 166-172. (Pubitemid 350256604)